Pharmacotherapy changes following pacemaker implantation in patients with bradycardia–tachycardia syndrome

Bibliography

• SHORT DS: The syndrome of alternating bradycardia and tachycardia. Br. Heart J. (1954) 16(2):208-214.
   PubMedGoogle Scholar
• FERRER MI: The sick sinus syndrome. Circulation (1973) 47(3):635-641.
   PubMed Web of Science ®Google Scholar
• BIGGER JT, JR., REIFFEL JA: Sick sinus syndrome. Ann. Rev. Med. (1979) 30:91-118.
   PubMed Web of Science ®Google Scholar
• AGGARWAL RK, RAY SG, CONNELLY DT et al.: Trends in pacemaker mode prescription 1984-1994: a single centre study of 3710 patients. Heart (1996) 75(5):518-521.
   PubMedGoogle Scholar
• BERNSTEIN AD, PARSONNET V: Survey of cardiac pacing and defibrillation in the United States in 1993. Am. J. Cardiol. (1996) 78(2):187-196.
   PubMed Web of Science ®Google Scholar
• LAMAS GA, PASHOS CL, NORMAND SL et al.: Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation (1995) 91(4):1063-1069.
   PubMedGoogle Scholar
• GREGORATOS G, ABRAMS J, EPSTEIN AE et al.: ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J. Am. Coll. Cardiol. (2002) 40(9):1703-1719.
   PubMed Web of Science ®Google Scholar
• SAKSENA S, PRAKASH A, HILL M et al.: Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J. Am. Coll. Cardiol. (1996) 28(3):687-694.
   PubMedGoogle Scholar
• ATTUEL P, PELLERIN D, MUGICA J et al.: DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. Pacing Clin. Electrophysiol. (1988) 11(11 Pt 2):1647-1654.
   PubMedGoogle Scholar
• SAKSENA S, PANTOPOULOS D, PARSONNET V et al.: Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia. Am. J. Cardiol. (1986) 58(1):70-74.
   PubMedGoogle Scholar
• DREIFUS LS, MICHELSON EL, KAPLINSKY E: Bradyarrhythmias: clinical significance and management. J. Am. Coll. Cardiol. (1983) 1(1):327-338.
   PubMed Web of Science ®Google Scholar
• PODRID PJ: Aggravatiom of arrhythmia by antiarrhythmic drugs. In: Cardiac Arrhythmia. Mechanismas, Diagnosis and Management. Podrid PJ, Kowey PR (Eds), Williams & Wilkins, Baltimore, MD, USA (1995):507-522.
   Google Scholar
• YUSUF S, CAMM AJ: Sinus tachyarrhythmias and the specific bradycardiac agents: a marriage made in heaven? J. Cardiovasc. Pharmacol. Ther. (2003) 8(2):89-105.
   PubMedGoogle Scholar
• ISRAEL CW, EHRLICH MD, BAROLD SS et al.: Treatment of atrial tachyarrhythmias with pacing and antiarrhythmic drugs. In: Advances in the Treatment of Atrial Tachyarrhythmias: Pacing, Cardioversion, and Defibrillation. Israel CW, Barold SS (Eds), Futura, Armonk, New York, NY, USA (2002):305-323.
   Google Scholar
• REIFFEL J: Maintenance of normal sinus rhythm with antiarrhythmic drugs. In: Atrial Fibrillation. Kowey PR, Naccarelli GV (Eds), Marcel Dekker, New York, NY, USA (2005):195-217.
   Google Scholar
• OVSYSHCHER IE, BAROLD SS: Drug induced bradycardia: to pace or not to pace? Pacing Clin. Electrophysiol. (2004) 27(8):1144-1147.
   PubMedGoogle Scholar
• STANTON MS, PRYSTOWSKY EN, FINEBERG NS et al.: Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation. J. Am. Coll. Cardiol. (1989) 14(1):209-215.
   PubMed Web of Science ®Google Scholar
• ESSEBAG V, HADJIS T, PLATT RW et al.: Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J. Am. Coll. Cardiol. (2003) 41(2):249-254.
   PubMed Web of Science ®Google Scholar
• ESSEBAG V, HADJIS T, PLATT RW et al.: Effect of amiodarone dose on the risk of permanent pacemaker insertion. Pacing Clin. Electrophysiol. (2004) 27(11):1519-1525.
   PubMedGoogle Scholar
• WEINFELD MS, DRAZNER MH, STEVENSON WG et al.: Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure. J. Heart Lung Transplant. (2000) 19(7):638-643.
   PubMedGoogle Scholar
• SWEENEY MO, HELLKAMP AS, ELLENBOGEN KA et al.: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 107(23):2932-2937.
   PubMed Web of Science ®Google Scholar
• WILKOFF BL, COOK JR, EPSTEIN AE et al.: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA (2002) 288(24):3115-3123.
   PubMed Web of Science ®Google Scholar
• BAROLD SS, BAROLD HS: Optimal cardiac pacing in patients with coronary artery disease. Pacing Clin. Electrophysiol. (1998) 21(2):456-461.
   PubMedGoogle Scholar
• GASPARINI M, MANTICA M, GALIMBERTI P et al.: Relief of drug refractory angina by biventricular pacing in heart failure. Pacing Clin. Electrophysiol. (2003) 26(1 Pt 2):181-184.
   PubMedGoogle Scholar
• NOWINSKI K, WECKE L, GADLER F et al.: Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy-observations on cardiac memory. Pacing Clin. Electrophysiol. (2005) 28(6):561-567.
   PubMedGoogle Scholar
• HONDA T, SHONO H, KOYAMA J et al.: Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy. Circ. J. (2005) 69(5):536-542.
   PubMedGoogle Scholar
• GADLER F, LINDE C, DARPO B: Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy. Eur. Heart J. (1998) 19(1):132-138.
   PubMedGoogle Scholar
• ANDERSEN HR, NIELSEN JC, THOMSEN PE et al.: Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet (1997) 350(9086):1210-1216.
   PubMed Web of Science ®Google Scholar
• LAMAS GA, LEE KL, SWEENEY MO et al.: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N. Engl. J. Med. (2002) 346(24):1854-1862.
   PubMed Web of Science ®Google Scholar
• RUCINSKI P, KUTARSKI A, WDOWIAK L: Impact of atrial fibrillation history on atrioventricular block appearance in patients with sinus node disease and single chamber atrial pacemaker. Cost–benefit consideration. Eur. Heart J. (2004) 24(Suppl.):602.
   Google Scholar
• ANDERSEN HR, NIELSEN JC, THOMSEN PE et al.: Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome. Circulation (1998) 98(13):1315-1321.
   PubMedGoogle Scholar
• BRANDT J, ANDERSON H, FAHRAEUS T et al.: Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J. Am. Coll. Cardiol. (1992) 20(3):633-639.
   PubMedGoogle Scholar
• KRISTENSEN L, NIELSEN JC, PEDERSEN AK et al.: AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. Pacing Clin. Electrophysiol. (2001) 24(3):358-365.
   PubMedGoogle Scholar
• KRISTENSEN L, NIELSEN JC, MORTENSEN PT et al.: Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart (2004) 90(6):661-666.
   PubMed Web of Science ®Google Scholar
• NIELSEN JC, KRISTENSEN L, ANDERSEN HR et al.: A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J. Am. Coll. Cardiol. (2003) 42(4):614-623.
   PubMed Web of Science ®Google Scholar
• ROSENQVIST M, OBEL IW: Atrial pacing and the risk for AV block: is there a time for change in attitude? Pacing Clin. Electrophysiol. (1989) 12(1 Pt 1):97-101.
   PubMedGoogle Scholar
• SUTTON R, KENNY RA: The natural history of sick sinus syndrome. Pacing Clin. Electrophysiol. (1986) 9(6 Pt 2):1110-1114.
   PubMedGoogle Scholar
• GILLIS AM, WYSE DG, CONNOLLY SJ et al.: Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation (1999) 99(19):2553-2558.
   PubMed Web of Science ®Google Scholar
• KNIGHT BP, GERSH BJ, CARLSON MD et al.: Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation (2005) 111(2):240-243.
   PubMed Web of Science ®Google Scholar
• BLANC JJ, DE RL, MANSOURATI J et al.: Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace (2004) 6(5):371-379.
   PubMedGoogle Scholar
• ISRAEL CW: Is there a role for pacing in the prevention of atrial tachyarrhythmias? Europace (2004) 6(5):380-383.
   PubMedGoogle Scholar
• DELFAUT P, SAKSENA S, PRAKASH A et al.: Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J. Am. Coll. Cardiol. (1998) 32(7):1900-1908.
   PubMedGoogle Scholar
• SAKSENA S, PRAKASH A, ZIEGLER P et al.: Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J. Am. Coll. Cardiol. (2002) 40(6):1140-1150.
   PubMedGoogle Scholar
• ISRAEL CW, HUGL B, UNTERBERG C et al.: Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J. Cardiovasc. Electrophysiol. (2001) 12(10):1121-1128.
   PubMedGoogle Scholar
• LEE MA, WEACHTER R, POLLAK S et al.: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J. Am. Coll. Cardiol. (2003) 41(11):1926-1932.
   PubMed Web of Science ®Google Scholar
• BORIANI G, PADELETTI L, SANTINI M et al.: Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J. Cardiovasc. Electrophysiol. (2005) 16(7):714-723.
   PubMedGoogle Scholar
• GRANT SC, BENNETT DH: Atrial latency in a dual chambered pacing system causing inappropriate sequence of cardiac chamber activation. Pacing Clin. Electrophysiol. (1992) 15(1):116-118.
   PubMedGoogle Scholar
• LEVINE PA, LOVE CJ: Pacemaker diagnostics and evaluation of pacing system malfunction. In: Clinical Cardiac Pacing and Defibrillation. Ellenbogen KA, Kay GN, Wilkoff BL (Eds), WB Saunders Company, Philadelphia, PA, USA (2000):827-875.
   Google Scholar
• SCHUCHERT A, MEINERTZ T: Acute effects of a class IA antiarrhythmic drug on the ventricular evoked response amplitude in patients with cardiac pacemakers. Cardiology (2000) 94(2):103-105.
   PubMedGoogle Scholar
• ALBONI P, RATTO B, CAPPATO R et al.: Clinical effects of oral theophylline in sick sinus syndrome. Am. Heart J. (1991) 122(5):1361-1367.
   PubMedGoogle Scholar
• SAITO D, MATSUBARA K, YAMANARI H et al.: Effects of oral theophylline on sick sinus syndrome. J. Am. Coll. Cardiol. (1993) 21(5):1199-1204.
   PubMedGoogle Scholar
• AVERY PG, SMALL J, SHAW DB: Xamoterol in sinus node disease. Int. J. Cardiol. (1993) 40(1):45-49.
   PubMedGoogle Scholar
• ALBONI P, MENOZZI C, BRIGNOLE M et al.: Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation (1997) 96(1):260-266.
   PubMed Web of Science ®Google Scholar
• CAWLEY MJ, AL-JAZAIRI AS, STONE EA: Intravenous theophylline – an alternative to temporary pacing in the management of bradycardia secondary to AV nodal block. Ann. Pharmacother. (2001) 35(3):303-307.
   PubMedGoogle Scholar
• LAMAS GA, LEE K, SWEENEY M et al.: The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am. Heart J. (2000) 140(4):541-551.
   PubMedGoogle Scholar
• SAKSENA S, DELFAUT P, PRAKASH A et al.: Multisite electrode pacing for prevention of atrial fibrillation. J. Cardiovasc. Electrophysiol. (1998) 9(8 Suppl.):S155-S162.
   Google Scholar
• BOCCADAMO R, DI BN, MAMMUCARI A et al.: Dual site right atrial pacing in the prevention of symptomatic atrial fibrillation refractory to drug therapy and unrelated to sinus bradycardia. J. Interv. Card Electrophysiol. (2002) 6(2):141-147.
   PubMedGoogle Scholar
• D’ALLONNES GR, PAVIN D, LECLERCQ C et al.: Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J. Cardiovasc. Electrophysiol. (2000) 11(10):1081-1091.
   PubMedGoogle Scholar
• COPLEN SE, ANTMAN EM, BERLIN JA et al.: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation (1990) 82(4):1106-1116.
   PubMed Web of Science ®Google Scholar
• WYSE DG, WALDO AL, DIMARCO JP et al.: A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. (2002) 347(23):1825-1833.
   PubMed Web of Science ®Google Scholar
• AFFIRM FIRST ANTIARRHYTHMIC DRUG SUBSTUDY INVESTIGATORS: Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J. Am. Coll. Cardiol. (2003) 42(1):20-29.
   PubMedGoogle Scholar
• JUUL-MOLLER S, EDVARDSSON N, REHNQVIST-AHLBERG N: Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation (1990) 82(6):1932-1939.
   PubMed Web of Science ®Google Scholar
• GOSSELINK AT, CRIJNS HJ, VAN G et al.: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA (1992) 267(24):3289-3293.
   PubMed Web of Science ®Google Scholar
• FLAKER GC, BLACKSHEAR JL, MCBRIDE R et al.: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J. Am. Coll. Cardiol. (1992) 20(3):527-532.
   PubMed Web of Science ®Google Scholar
• RUCINSKI P, KUTARSKI A, SZCZASNY M et al.: Pharmacotherapy profile changes after pacemaker implantation in patients with bradycardia-tachycardia syndrome. Eur. Heart J. (2005) 26(Suppl.1):579.
   Google Scholar
• WOLPERT C, HAASE KK, SUSELBECK T et al.: Hybrid therapy for atrial fibrillation. Eur. Heart J. Suppl. (2003) 5(Suppl. H):H51-H55.
   Google Scholar
• KROL RB, SAKSENA S, PRAKASH A: New devices and hybrid therapies and new devices for treatment of atrial fibrillation. J. Interv. Card. Electrophysiol. (2000) 4(Suppl. 1):163-169.
   PubMed Web of Science ®Google Scholar
• SAKSENA S, MADAN N: Hybrid therapy of atrial fibrillation: algorithms and outcome. J. Interv. Card. Electrophysiol. (2003) 9(2):235-247.
   PubMed Web of Science ®Google Scholar
• GARRIGUE S, BAROLD SS, CAZEAU S et al.: Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin. Electrophysiol. (1998) 21(9):1751-1759.
   PubMedGoogle Scholar
• PRAKASH A, DELFAUT P, KROL RB et al.: Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am. J. Cardiol. (1998) 82(10):1197-1204.
   PubMedGoogle Scholar
• DAUBERT JC, PAVIN D, JAUVERT G et al.: Intra- and interatrial conduction delay: implications for cardiac pacing. Pacing Clin. Electrophysiol. (2004) 27(4):507-525.
   PubMed Web of Science ®Google Scholar
• ABE Y, FUKUNAMI M, YAMADA T et al.: Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation (1997) 96(8):2612-2616.
   PubMed Web of Science ®Google Scholar
• LAU CP, TSE HF, YU CM et al.: Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am. J. Cardiol. (2001) 88(4):371-375.
   PubMedGoogle Scholar
• MADAN N, SAKSENA S: Long-term rhythm control of drug-refractory atrial fibrillation with ‘hybrid therapy’ incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. Am. J. Cardiol. (2004) 93(5):569-575.
   PubMedGoogle Scholar
• LAU CP: Pacing for atrial fibrillation. Heart (2003) 89(1):106-112.
   PubMedGoogle Scholar
• SWEENEY MO, HELLKAMP AS, ELLENBOGEN KA et al.: Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction. J. Cardiovasc. Electrophysiol. (2004) 15(2):153-160.
   PubMed Web of Science ®Google Scholar
• GLOTZER TV, HELLKAMP AS, ZIMMERMAN J et al.: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial (MOST). Circulation (2003) 107(12):1614-1619.
   PubMed Web of Science ®Google Scholar
• FLAMMANG D, LOTEANU V, HAMANI D et al.: Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study. Europace (2005) 7(5):482-489.
   PubMedGoogle Scholar
• WILLEMS R, MORCK ML, EXNER DV et al.: Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome. Heart Rhythm (2004) 1(4):414-421.
   PubMed Web of Science ®Google Scholar
• MEHRA R, ZIEGLER P, KOEHLER J: Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies. Heart Rhythm (2004) 1(2 Suppl.):B64-B69, discussion.
   Google Scholar
• ISRAEL CW, NEUBAUER H, OLBRICH HG et al.: Incidence of atrial tachyarrhythmias in pacemaker patients: results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated patients (BEATS) study. Pacing Clin. Electrophysiol. (2006) 29(6):582-588.
   PubMed Web of Science ®Google Scholar
• MADAN N, EL-GABRY I, SAKSENA S: Withdrawal or maintenance of warfarin therapy guided by implantable device datalogs in patients with refractory atrial fibrillation: a novel application of device monitoring in recurrent atrial fibrillation. J. Am. Coll. Cardiol. (2005) 45:102A.
   Google Scholar
• FUSTER V, RYDEN LE, CANNOM DS et al.: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J. (2006) 27(16):1979-2030.
   PubMed Web of Science ®Google Scholar
• RAWLES JM, METCALFE MJ, JENNINGS K: Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br. Heart J. (1990) 63(4):225-227.
   PubMedGoogle Scholar
• ISRAEL CW, GRONEFELD G, EHRLICH JR et al.: Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J. Am. Coll. Cardiol. (2004) 43(1):47-52.
   PubMed Web of Science ®Google Scholar
• LAU CP, JIANG ZY, TANG MO: Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fibrillation. Pacing Clin. Electrophysiol. (1998) 21(3):542-548.
   PubMedGoogle Scholar
• GREENHUT SE, FRASER J, STEINHAUS B et al.: Optimized standby rate reduces the ventricular rate variability in pacemaker patients with atrial fibrillation. Pacing Clin. Electrophysiol. (1996) 19(11 Pt 2):1780-1785.
   PubMedGoogle Scholar
• HART RG, HALPERIN JL, PEARCE LA et al.: Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. (2003) 138(10):831-838.
   PubMed Web of Science ®Google Scholar
• GILIS AM, PURERFELLNER H, ISRAEL CW et al.: Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin. Electrophysiol. (2006) 29(7):697-705
   PubMedGoogle Scholar
• CHOUDHURY A, VARUGHESE GI, LIP GY: Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy? Expert. Opin. Pharmacother. (2005) 6(13):2193-2207.
   PubMed Web of Science ®Google Scholar
• SIU CW, LAU CP, TSE HF: Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am. J. Cardiol. (2003) 92(11):1343-1345.
   PubMed Web of Science ®Google Scholar
• MOZAFFARIAN D, PSATY BM, RIMM EB et al.: Fish intake and risk of incident atrial fibrillation. Circulation (2004) 110(4):368-373.
   PubMed Web of Science ®Google Scholar